Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment

Edwards, 2004, Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections, Eur. J. Clin. Microbiol. Infect. Dis., 23, 233, 10.1007/s10096-004-1113-9 Parola, 2007, Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006, Am. J. Trop. Med. Hyg., 77, 431, 10.4269/ajtmh.2007.77.431 Huang, 1997, Inhibitory effects of curcumin on tumorigenesis in mice, J. Cell. Biochem. Suppl., 27, 26, 10.1002/(SICI)1097-4644(1997)27+<26::AID-JCB7>3.0.CO;2-3 Huang, 1995, Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion, Carcinogenesis, 16, 2493, 10.1093/carcin/16.10.2493 Changtam, 2010, Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species, Eur. J. Med. Chem., 45, 941, 10.1016/j.ejmech.2009.11.035 Peng, 2010, Pivotal role of curcuminoids on the antimutagenic activity of Curcuma zedoaria extracts, Drug Chem. Toxicol., 33, 64, 10.3109/01480540903170738 Haukvik, 2009, Photokilling of bacteria by curcumin in different aqueous preparations. Studies on curcumin and curcuminoids XXXVII, Pharmazie, 64, 666 Aftab, 2010, Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals, Phytother. Res., 24, 500 Shytle, 2009, Optimized turmeric extracts have potent anti-amyloidogenic effects, Curr. Alzheimer Res., 6, 564, 10.2174/156720509790147115 Gowda, 2009, Antioxidant efficacy of curcuminoids from turmeric (Curcuma longa L.) powder in broiler chickens fed diets containing aflatoxin B1, Br. J Nutr., 102, 1629, 10.1017/S0007114509990869 Mishra, 2009, Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin, Malar. J., 8, 26, 10.1186/1475-2875-8-26 Mulabagal, 2010, Development of binding assays to screen ligands for Plasmodium falciparum thioredoxin and glutathione reductases by ultrafiltration and liquid chromatography/mass spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 878, 987, 10.1016/j.jchromb.2010.02.030 Nandakumar, 2006, Curcumin-artemisinin combination therapy for malaria, Antimicrob. Agents Chemother., 50, 1859, 10.1128/AAC.50.5.1859-1860.2006 Reddy, 2005, Curcumin for malaria therapy, Biochem. Biophys. Res. Commun., 326, 472, 10.1016/j.bbrc.2004.11.051 Jain, 2007, Standardization and stability studies of neuroprotective lipid soluble fraction obtained from Curcuma longa, J. Pharm. Biomed. Anal., 44, 1079, 10.1016/j.jpba.2007.05.009 Martins, 2007, Lipid-based colloidal carriers for peptide and protein delivery—liposomes versus lipid nanoparticles, Int. J. Nanomed., 2, 595 Almeida, 2007, Solid lipid nanoparticles as a drug delivery system for peptides and proteins, Adv. Drug Deliv. Rev., 59, 478, 10.1016/j.addr.2007.04.007 Muller, 2002, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev., 54, S131, 10.1016/S0169-409X(02)00118-7 Souto, 2010, Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes, Handb. Exp. Pharmacol., 115, 10.1007/978-3-642-00477-3_4 Souto, 2009, A special issue on lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines), J. Biomed. Nanotechnol., 5, 315, 10.1166/jbn.2009.1040 Souto, 2009, Chapter 6—solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery, Methods Enzymol., 464, 105, 10.1016/S0076-6879(09)64006-4 Aditya, 2010, Arthemeter-loaded lipid nanoparticles produced by modified-thin film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity, Eur. J. Pharm. Sci., 40, 448, 10.1016/j.ejps.2010.05.007 Sou, 2008, Loading of curcumin into macrophages using lipid-based nanoparticles, Int. J. Pharm., 352, 287, 10.1016/j.ijpharm.2007.10.033 Tiyaboonchai, 2007, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int. J. Pharm., 337, 299, 10.1016/j.ijpharm.2006.12.043 Yallapu, 2010, Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth, J. Ovarian Res., 3, 11, 10.1186/1757-2215-3-11 Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J. Nanobiotechnol., 5, 3, 10.1186/1477-3155-5-3 Tonnesen, 1994, Studies on curcumin and curcuminoids: XXV. Inhibition of primaquine-induced lysis of human red blood cells by curcumin, Int. J. Pharm., 110, 161, 10.1016/0378-5173(94)90154-6 Mehnert, 2001, Solid lipid nanoparticles: production, characterization and applications, Adv. Drug Deliv. Rev., 47, 165, 10.1016/S0169-409X(01)00105-3 Jenning, 2000, Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids, Int. J. Pharm., 199, 167, 10.1016/S0378-5173(00)00378-1 Teeranachaideekul, 2008, Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC, J. Control. Release, 128, 134, 10.1016/j.jconrel.2008.02.011 Vivek, 2007, Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles, AAPS PharmSciTech, 8, E83, 10.1208/pt0804083 Manzan, 2003, Extraction of essential oil and pigments from Curcuma longa [L] by steam distillation and extraction with volatile solvents, J. Agric. Food Chem., 51, 6802, 10.1021/jf030161x Ansari, 2005, Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations, J. Pharm. Biomed. Anal., 39, 132, 10.1016/j.jpba.2005.03.021 Heiati, 1998, Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization, J. Microencapsul., 15, 173, 10.3109/02652049809006847 Hu, 2002, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization, Int. J. Pharm., 239, 121, 10.1016/S0378-5173(02)00081-9 Ohshima, 2009, Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution, Int. J. Pharm., 377, 180, 10.1016/j.ijpharm.2009.05.004 Jumaa, 1999, Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers, Pharm. Acta Helv., 76, 293, 10.1016/S0031-6865(99)00003-5 Zimmermann, 2000, Influence of different parameters on reconstitution of lyophilized SLN, Int. J. Pharm., 196, 211, 10.1016/S0378-5173(99)00424-X Li, 2005, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis, Cancer, 104, 1322, 10.1002/cncr.21300 Souto, 2004, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int. J. Pharm., 278, 71, 10.1016/j.ijpharm.2004.02.032 Konan, 2003, Preparation and characterization of sterile sub-200nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy, Eur. J. Pharm. Biopharm., 55, 115, 10.1016/S0939-6411(02)00128-5 Konan, 2002, Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles, Int. J. Pharm., 233, 239, 10.1016/S0378-5173(01)00944-9 Pan, 1999, Biotransformation of curcumin through reduction and glucuronidation in mice, Drug Metab. Dispos., 27, 486 Ireson, 2001, Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production, Cancer Res., 61, 1058 Krugliak, 1995, Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo, Exp. Parasitol., 81, 97, 10.1006/expr.1995.1097 Kumaratilake, 1992, Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei, J. Clin. Invest., 89, 961, 10.1172/JCI115678 Varalakshmi, 2008, Immunomodulatory effects of curcumin: in-vivo, Int. Immunopharmacol., 8, 688, 10.1016/j.intimp.2008.01.008 Singh, 2006, Biological effects of curcumin and its role in cancer chemoprevention and therapy, Anticancer Agents Med. Chem., 6, 259, 10.2174/187152006776930918 Targett, 1992, Malaria: drug use and the immune response, Parasitology, 105, S61, 10.1017/S0031182000075363 Agrawal, 2001, Enhanced immunostimulant activity and protective effect of a synthetic lipopeptide after liposomization against Plasmodium berghei infection in mice, J. Drug Targets, 9, 231, 10.3109/10611860108997932